Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000040135 | SCV000063826 | benign | not specified | 2012-07-03 | criteria provided, single submitter | clinical testing | 0.7% (26/3816) of Afr Amer chrom from ESP |
Gene |
RCV000040135 | SCV000169226 | benign | not specified | 2014-04-20 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000040135 | SCV000225733 | benign | not specified | 2014-12-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000231622 | SCV000286577 | benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2025-01-31 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000040135 | SCV001361744 | likely benign | not specified | 2019-11-16 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001811291 | SCV002048764 | benign | not provided | 2020-10-20 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839577 | SCV002101792 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2J | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839578 | SCV002101793 | benign | Myopathy, myofibrillar, 9, with early respiratory failure | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839579 | SCV002101794 | benign | Early-onset myopathy with fatal cardiomyopathy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839576 | SCV002101795 | benign | Tibial muscular dystrophy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001811291 | SCV004152485 | likely benign | not provided | 2024-04-01 | criteria provided, single submitter | clinical testing | TTN: BP4, BP7 |